Industry Background:
Atherectomy is a process that is performed to remove atherosclerotic plaque from diseased arteries. Atherosclerotic plates are limited in either coronary or peripheral arterial vasculature and may have different features depending on the quality of the plaque. Coronary atherectomy devices has been used efficiently in the treatment of both coronary and peripheral arterial disease. Coronary atherectomy devices are designed differently to either cut, shave or vaporize these plaques and have different indications.
This growth is primarily driven by Rising Number of Patients Suffering from Atherosclerosis, Diabetes, and Obesity.
Globally, a noticeable market trend is evident Increasing Incidence of Vascular Diseases and Disorders Related To Calcified Peripheral
. Major Players, such as Boston Scientific Corporation (United States), Avinger, Inc. (United States), Cardiovascular Systems, Inc. (United States), Medtronic (Ireland), Royal Philips (Netherlands), Straub Medical (Switzerland), B. Braun Group (Germany), Abbott Laboratories (United States), Terumo Corporation (Japan) and Biomerics (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
On June 11, 2019 - Boston Scientific Corporation has announced that it has closed its acquisition of Vertiflex, Inc., a privately-held company that developed and commercialized the Superion Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS) the narrowing of the spinal canal, which can cause compression of nearby nerves. and On June 27, 2019 - Medtronic plc, a global leader in medical technology, announced it has completed the acquisition of Titan Spine, a privately-held titanium spine interbody implant and surface technology company. Titan Spine pioneered and leads the category of surface-enhanced titanium interbody implants with its unique nanoLOCK platform.
On April 10, 2019 - Avinger, Inc., a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD) has announced that the Company received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pantheris SV (Small Vessel) image-guided atherectomy system.
Market Drivers
- Rising Number of Patients Suffering from Atherosclerosis, Diabetes, and Obesity
Market Trend
- Increasing Incidence of Vascular Diseases and Disorders Related To Calcified Peripheral
- Continuous Product Development and Commercialization
Restraints
- Lack of Quality Professionals
- Limited Patient Awareness Related to Disease Diagnosis
Opportunities
Infrastructural Development in Developing Regions and Increasing Demand for Vascular and Coronary Intervention
Challenges
High Cost Related to Coronary Atherectomy Devices
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Coronary Atherectomy Devices Study Sheds Light on
The Coronary Atherectomy Devices Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Coronary Atherectomy Devices industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Coronary Atherectomy Devices industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.